Skip to main content

DYSPORT A (Ipsen Pty Ltd)

Product name
DYSPORT A
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
199 working days (255)
Active ingredients
clostridium botulinum type a toxin haemagglutinin complex
Registration type
EOI
Indication

DYSPORT (powder for injection) is now also indicated for symptomatic treatment of focal spasticity of upper limbs in children aged 2 years and older.

Help us improve the Therapeutic Goods Administration site